The destruction of retinal ganglion cells caused by the type II transmembrane protein Fas ligand (Fasl) is a key factor in glaucoma pathogenesis. Meredith Gregory-Ksander, PhD, Assistant Professor of...
Gena Heidary, MD, PhD, Assistant Professor of Ophthalmology and Director of Ophthalmology Fellowship Training at Boston Children's Hospital, has been selected to participate in the Association for...
Deborah K. VanderVeen, MD, Associate Professor of Ophthalmology at Harvard Medical School and a clinician scientist at Boston Children's Hospital, has been elected to the prestigious American...
Leo A. Kim, MD, PhD,a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of...
The destruction of retinal ganglion cells caused by the type II transmembrane protein Fas ligand (Fasl) is a key factor in glaucoma pathogenesis. 
Gena Heidary, MD, PhD
Deborah K. VanderVeen, MD
Leo A. Kim, MD, PhD,